AceLink Therapeutics is involved in drug development, focusing on glycolipid biology and rare genetic diseases. The company collaborates with contract research organizations and academic leaders to transform scientific discoveries into therapies.

AceLink Therapeutics

AceLink Therapeutics | 437 followers on LinkedIn. Overcome genetic diseases, one at a time | AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associated human diseases with the initial focus on a small molecule drug for polycystic kidney disease (PKD), a human genetic disease with 12 million patients worldwide.

Yuqiao (Jerry) Shen

VP, Research & Early Development at AceLink Therapeutics

ACEL

COM:ACELINKTHERAPEUTICS

AceLink Therapeutics